Shanly C. Seferina

Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium

Shanly C. Seferina, Maaike de Boer, M. Wouter Derksen et al. · The Oncologist · 2016 · 43 citations · Full text

Medicine, Cardiology, Oncology +17

Real-Life Use and Effectiveness of Adjuvant Trastuzumab in Early Breast Cancer Patients: A Study of the Southeast Netherlands Breast Cancer Consortium

Shanly C. Seferina, D.J.A. Lobbezoo, Maaike de Boer et al. · The Oncologist · 2015 · 36 citations · Full text

Medicine, Oncology, Pharmacology +16

Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium

Shanly C. Seferina, Bram Ramaekers, Maaike de Boer et al. · Oncotarget · 2017 · 26 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +14

Reliability of receptor assessment on core needle biopsy in breast cancer patients

Shanly C. Seferina, M. Nap, F. Van den Berkmortel et al. · Tumor Biology · 2012 · 23 citations

Medicine, Oncology, Pathology +14